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Abstract
Background: Prostaglandin E2 (PGE2) is involved in several chronic inflammatory diseases including periodontitis, 
which causes loss of the gingival tissue and alveolar bone supporting the teeth. We have previously shown that tumor 
necrosis factor α (TNFα) induces PGE2 synthesis in gingival fibroblasts. In this study we aimed to investigate the global 
gene expression profile of TNFα-stimulated primary human gingival fibroblasts, focusing on signal pathways related to 
the PGE2-synthesizing enzymes prostaglandin E synthases (PGES), as well as the upstream enzyme cyclooxygenase-2 
(COX-2) and PGE2 production.
Results: Microarray and western blot analyses showed that the mRNA and protein expression of the inflammatory 
induced microsomal prostaglandin E synthase-1 (mPGES-1) was up-regulated by the cytokine TNFα, accompanied by 
enhanced expression of COX-2 and increased production of PGE2. In contrast, the expression of the isoenzymes 
microsomal prostaglandin E synthase-2 (mPGES-2) and cytosolic prostaglandin E synthase (cPGES) was unaffected by 
TNFα treatment. Using oligonucleotide microarray analysis in a time-course factorial design including time points 1, 3 
and 6 h, differentially expressed genes in response to TNFα treatment were identified. Enrichment analysis of 
microarray data indicated two positively regulated signal transduction pathways: c-Jun N-terminal kinase (JNK) and 
Nuclear Factor-κB (NF-κB). To evaluate their involvement in the regulation of mPGES-1 and COX-2 expression, we used 
specific inhibitors as well as phosphorylation analysis. Phosphorylation analysis of JNK (T183/Y185) and NF-κB p65 
(S536) showed increased phosphorylation in response to TNFα treatment, which was decreased by specific inhibitors 
of JNK (SP600125) and NF-κB (Bay 11-7082, Ro 106-9920). Inhibitors of JNK and NF-κB also decreased the TNFα-
stimulated up-regulation of mPGES-1 and COX-2 as well as PGE2 production.
Conclusion: In the global gene expression profile, the enrichment analysis of microarray data identified the two signal 
transduction pathways JNK and NF-κB as positively regulated by the cytokine TNFα. Inhibition of these TNFα-activated 
signal pathways reduced the expression of mPGES-1 and COX-2 as well as their end product PGE2 in gingival 
fibroblasts. The involvement of the signal pathways JNK and NF-κB in the regulation of PGE2 induced by TNFα may 
suggest these two pathways as possible attractive targets in the chronic inflammatory disease periodontitis.
Background
The chronic inflammatory disease periodontitis is char-
acterized by tissue and bone destruction. The current
concept of the etiology of periodontitis is that bacterial
components of the biofilm initiate the inflammatory cas-
cade, including infiltration of immune cells and produc-
tion of inflammatory mediators in the periodontal tissue.
The initial inflammation, gingivitis, may then develop
into a chronic inflammatory state of the gingiva causing
destruction of the gingival tissue as well as the alveolar
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bone resulting in decreased support for the teeth, and
ultimately tooth loss [1-3].
Among inflammatory mediators involved in periodon-
titis, prostaglandin E2 (PGE2) has been associated with
periodontitis as a potent stimulator of bone resorption,
and increased PGE2 levels have been reported in gingival
tissue and gingival fluid from patients with periodontitis
[4-9]. Moreover, administration of nonsteroidal anti-
inflammatory drugs (NSAID), inhibitors of PGE2 produc-
tion, has been shown to reduce the progression of alveo-
lar bone resorption in patients with periodontitis,
implying that PGE2 is a key mediator in the pathogenesis
of periodontal disease [10,11].
The proinflammatory cytokine TNFα is also reported
to play an important part in the pathogenesis of perio-
dontitis [12,13]. For instance, it has been shown that
attachment loss is decreased in periodontitis patients
after anti-TNF treatment, and subcutaneous administra-
tion of recombinant TNFα is demonstrated to exacerbate
experimental periodontitis in rats [14,15]. Also, the
chronic inflammatory condition rheumatoid arthritis,
which shares many characteristics with periodontitis, has
been successfully treated using TNFα blockers, further
highlighting TNFα as a key inflammatory mediator in
chronic inflammatory conditions [16-18]. We have previ-
ously shown that TNFα enhances the production of PGE2
in gingival fibroblasts, but the intracellular signal path-
ways regulating PGE2 production and PGE2-synthesizing
enzymes have still not been completely elucidated [4,19].
The biosynthesis of PGE2 from membrane lipids is cata-
lyzed by three groups of enzymes acting sequentially.
First, phospholipase A2  converts membrane lipids to
arachidonic acid [20,21]. The cyclooxygenases (COX-1
and COX-2) then convert arachidonic acid to prostaglan-
din H2 [22]. Finally, the third and most recently identified
group of isoenzymes is the prostaglandin E synthases
(PGE synthases) which catalyze the conversion of COX-
derived prostaglandin H2 to PGE2 [23,24]. Up to date,
three PGE synthases have been described: The
microsomal and inducible mPGES-1, the constitutively
expressed cytosolic cPGES and the most recently discov-
ered microsomal mPGES-2 [25-29]. We have previously
reported that mPGES-1 and COX-2 are up-regulated by
TNFα and IL-1β in gingival fibroblasts [4,30,31].
The inflammatory mediator PGE2 as well as the PGE2-
regulatory enzymes COX-2 and mPGES-1 have been
shown to be up-regulated by inflammatory stimuli such
as lipopolysaccharides, IL-1β and TNFα also in other cell
types, including gastric fibroblasts, synovial fibroblasts,
cardiac fibroblasts and gastric cancer cell lines [32-37].
Various intracellular signaling pathways have been
reported to be involved in inflammatory-induced PGE2
production and in the expression of PGE2-sythesizing
enzymes, although these pathways seem to be both cell-
and stimulus-specific. For example, in gingival fibro-
blasts, we have previously reported that the signal path-
ways PKC and p38 mitogen-activated protein kinase are
involved in the regulation of the cytokine-induced COX-
2 expression but not in the regulation of mPGES-1
expression [19]. In contrast, these two signal pathways
are demonstrated to be involved in cytokine-induced
mPGES-1 expression in colonocytes and orbital fibro-
blasts [19,38,39]. The differences between cell types and
between stimuli make it imperative to study the intracel-
lular regulation of mPGES-1 as well as COX-2 using a cell
t y p e  a n d  s t i m u l u s  w h i c h  i s  r e l e v a n t  t o  t h e  d i s e a s e  o f
interest. In periodontal tissue, the most ubiquitous resi-
dential cells are gingival fibroblasts. These cells, by pro-
ducing inflammatory mediators such as cytokines,
prostaglandins and proteolytic enzymes, participate in
the inflammatory response and contribute to disease per-
sistence [40-44].
In this work, we therefore aim to explore the signal
transduction pathways involved in the regulation of
PGE2-regulating enzymes mPGES-1 and COX-2 in
TNFα-stimulated primary gingival fibroblasts through a
global gene expression approach, using microarray tech-
nology. Our results show that the intracellular signal
transduction pathways JNK and NF-κB are involved in
the regulation of TNFα-induced mPGES-1 and COX-2
expression, as well as PGE2 production, in gingival fibro-
blasts.
Results
Effect of TNFα on protein expression of PGE synthases and 
COX-2 and production of PGE2
W e  h a v e  p r e v i o u s l y  r e p o r t e d  t h a t  t h e  i n f l a m m a t o r y
mediator TNFα stimulates PGE2  production via the
enzymes mPGES-1 and COX-2. In this study we aimed to
investigate the signal transduction pathways involved in
the regulation of mPGES-1, COX-2 and PGE2 in TNFα-
stimulated gingival fibroblasts through global gene
expression analysis. In agreement with our previous stud-
ies [4,30,31], the protein expression of mPGES-1 and
COX-2 was up-regulated by the inflammatory mediator
TNFα (20 ng/ml), as demonstrated by western blot analy-
sis (Figure 1A). The time-course analysis, using time
points 1, 3, 6 and 24 h, revealed that the stimulatory effect
of TNFα was strongest at the 24 h time point both for
mPGES-1 and COX-2. When comparing these two
enzymes, mPGES-1 expression increased starting from
the 6 h time point, whereas COX-2 expression time-
dependently increased starting from the 1 h time point in
response to TNFα stimulation. The expression of COX-2
also increased in cells not stimulated with TNFα in 24 hBåge et al. BMC Genomics 2010, 11:241
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cultures, as compared to earlier time points. In contrast
to mPGES-1 and COX-2, the expression of the PGE syn-
thase isoenzymes mPGES-2 and cPGES was not affected
by TNFα in gingival fibroblasts (Figure 1A). The western
blot results were also confirmed by flow cytometric anal-
ysis, revealing an up-regulation of mPGES-1 and COX-2
expression in 24 h cultures of TNFα-treated cells in con-
trast to mPGES-2 and cPGES expression (Figure 1B).
Moreover, the induction of mPGES-1 and COX-2 expres-
sion, in response to TNFα, resulted in a time-dependent
increase of PGE2 production, as shown in Figure 1C.
Effect of TNFα on mRNA expression of PGE synthases and 
COX-2
The mRNA expression of mPGES-1, mPGES-2, cPGES
and COX-2, as measured by oligonucleotide microarray,
is seen in Figure 2. The expression of mPGES-1 as well as
COX-2 was significantly up-regulated in response to
TNFα treatment at the time points indicated (1, 3 and 6
h). On the contrary, the PGE synthase isoenzymes
mPGES-2 and cPGES were not differentially expressed at
the above-mentioned time points (Figure 2), which is
consistent with the protein expression results. The
microarray used in this study contained two different
probes both for the mPGES-1 and cPGES genes, localized
to distinct parts of each mRNA transcript. These probes
resulted in similar results, and data from both probes was
used in the subsequent analysis.
Differential expression between TNFα-treated cells and 
control cells
In the microarray analysis, the mRNA samples from 1, 3
and 6 h cultures were hybridized according to the experi-
mental design illustrated in Figure 3A. We used a time-
course factorial design, which facilitated identification of
the genes that were differentially regulated between the
time points due to TNFα treatment with optimal statisti-
cal efficiency [45]. This design was repeated for all three
cell lines included in the study. The majority of the genes
Figure 1 Effect of TNFα on protein expression of PGE synthases 
and COX-2 and production of PGE2. (A) Gingival fibroblasts were 
treated with TNFα (20 ng/ml) or without TNFα for the indicated time 
period. Cells were harvested, total protein was extracted and protein 
expression of the PGE2-synthesizing enzymes mPGES-1, mPGES-2, 
cPGES and COX-2 as well as the loading control actin was analyzed by 
western blot. (B) Gingival fibroblasts were stimulated with TNFα (20 
ng/ml) or cultured without TNFα (control) for 24 h. Protein expression 
of mPGES-1, mPGES-2, cPGES and COX-2 was investigated by flow cy-
tometry, using specific antibodies. (C) Gingival fibroblasts were cul-
tured with or without TNFα (20 ng/ml) for the indicated time period. 
Levels of PGE2 in the culture media were measured by EIA on a Lumin-
ex system, and are presented as mean ± s.d. Asterisks (*) indicate a sig-
nificant difference from untreated cells at the corresponding time 
point (p < 0.05). The results are representative for all three cell lines and 
all analyses were performed in triplicates.
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Figure 2 Effect of TNFα on mRNA expression of PGE synthases 
and COX-2. Gingival fibroblasts were treated with TNFα (20 ng/ml) or 
without TNFα for the indicated time period. Total RNA was extracted 
from gingival fibroblasts, and mRNA expression of the PGE2 synthesiz-
ing enzymes mPGES-1, mPGES-2, cPGES and COX-2, was measured by 
microarray analysis, using specific probes for each enzyme. Two 
probes for each of the PGE synthase isoenzymes mPGES-1 and cPGES 
were present on the chip used in the microarray analysis. The y-axis dis-
plays the M-value which is the log2 of the ratio gene expression of 
TNFα treated cells/gene expression of control cells. A positive number 
corresponds to higher expression in the TNFα treated cells. The x-axis 
corresponds to the different time points. A filled circle denotes a signif-
icant differentially expressed gene at the indicated time point whereas 
an empty circle denotes no significant difference.
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that were significantly differentially expressed (differen-
tial expression defined as a false discovery rate < 0.05)
were up-regulated in the TNFα-treated cells, which is
illustrated in the volcano plots in Figure 3B-D. A positive
M-value denotes genes up-regulated by TNFα whereas
down-regulated genes have a negative M-value. The
results showed that 1157 genes were differentially
expressed between the TNFα-treated and control fibro-
blasts after 1 h incubation (Figure 3B). In the comparison
between 1 h and 3 h, 796 differentially expressed genes
were found (Figure 3C), and 553 genes were differentially
expressed between 3 h and 6 h (Figure 3D).
Gene Ontology analysis of differentially expressed genes
Enrichment analysis was performed to identify overrep-
resented gene ontology (GO) categories among the dif-
ferentially expressed genes in the different comparisons.
The gene ontology categories represent classes of genes
in which more of the individual genes, included in the
particular class, are differentially expressed in this data
set than would be expected by a random distribution of
differentially expressed genes. Complete lists of differen-
tially expressed genes and significant GO categories are
presented in the additional material (Additional files 1, 2,
3, 4, 5, 6, 7, 8 and 9).
The analysis of the differentially expressed genes at
time point 1 h gave a GO profile indicative of TNFα
involvement, where significant categories were immune
response, regulation, and apoptosis related (Additional
file 2). The same types of categories were also significant
due to TNFα-treatment between the 1 h and 3 h time
points, signifying that genes annotated to those catego-
ries were actively regulated between 1 h and 3 h (Figure 4,
for a complete list see Additional file 5). Interestingly,
positive regulation of two distinct signaling pathways,
"positive regulation of I-kappaB kinase/NF-kappaB cas-
cade" and "positive regulation of JNK cascade", was iden-
tified by the enrichment analysis in the comparison of 1 h
and 3 h of TNFα treatment, as demonstrated in Figure 4.
The differentially expressed genes included in these two
GO categories are listed in Table 1, together with the
genes of the PGE2-synthesizing enzymes PGE synthases
and COX-2 for comparison of M-values, fold changes and
p values. For instance, in the category "positive regulation
of I-kappaB kinase/NF-kappaB cascade", the gene for
inhibitor of kappa light polypeptide gene enhancer in B-
cells, kinase epsilon (IKBKE), which stimulates the disso-
ciation of NF-κB and its inhibitor [46], was found to be
up-regulated by TNFα treatment (Table 1). Furthermore,
the comparison of 1 h to 6 h gene expression results
showing M-values, fold changes and p values for PGE
synthases and COX-2 are presented in Table 2.
When comparing the 3 h and 6 h time points, fewer GO
categories were significant than for the 1 h as well as 1 h
to 3 h comparisons (26 terms for 1 h, 29 terms for 1 h to 3
h and 10 terms for 3 h to 6 h, see Additional files 2, 5 and
8). Of the two positively regulated signal cascades found
in the 1 h to 3 h comparison, only "positive regulation of
I-kappaB kinase/NF-kappaB cascade" was significantly
changed between 3 h and 6 h. Other significant categories
between 3 h and 6 h were mainly immune related (see
additional file 8). For the three cell lines used, differential
expression of the genes included in the GO categories
"positive regulation of JNK cascade" and "positive regula-
tion of I-kappaB kinase/NF-kappaB cascade" in the 1 h to
3 h comparison is also displayed in a heat map in Figure 5.
Since the focus of this study was on signal transduction
pathways, we proceeded to further explore the potential
role of the two positively regulated intracellular signaling
pathways NF-κB and JNK, identified in the 1 h to 3 h
Figure 3 Microarray experimental design and volcano plots dis-
playing differential expression between TNFα-treated and con-
trol cells. (A) For each of the three gingival fibroblast cell lines, cells 
were treated with TNFα (20 ng/ml) or cultured without TNFα for 1, 3 or 
6 h. Samples were labeled and hybridized on oligonucleotide microar-
rays. Each arrow corresponds to one hybridization where the green 
sample is labeled with Cy3 and the red sample with Cy5. (B-D) The y 
axis displays the negative false discovery rate (-FDR) on a log10 scale 
and the x axis displays the M-value which is the log2 of the ratio gene 
expression of TNFα treated cells/gene expression of control cells. A 
positive M-value corresponds to higher expression in the TNFα treated 
cells. The vertical line signifies a false discovery rate of 0.05, and all 
genes above it are considered differentially expressed. (B) At time 
point 1 h, 1157 genes were differentially expressed in response to 
TNFα. For (C) and (D), the differentially expressed genes at the later 
time point were compared with the differentially expressed genes at 
the earlier time point, to retrieve the genes that were differentially ex-
pressed due to time and treatment between those time points. (C) Be-
tween time points 1 h and 3 h, 796 genes were differentially regulated 
due to TNFα treatment. (D) Between time points 3 h and 6 h, 553 
genes were differentially regulated due to TNFα treatment.
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comparison, in the regulation of TNFα-induced mPGES-
1 and COX-2 expression. For this purpose, we investi-
gated the effect of specific inhibitors of the JNK and NF-
κB signal pathways on the expression of mPGES-1 and
COX-2 as well as on the phosphorylation of these two
pathways.
Involvement of JNK in the regulation of mPGES-1 and COX-2
To investigate the involvement of the JNK signal pathway
in TNFα-induced mPGES-1 and COX-2 expression and
PGE2 production, gingival fibroblasts were treated with
the specific JNK inhibitor SP600125 (SP) [47]. Treatment
of the cells with SP (10 μM) together with TNFα
decreased the protein expression of both mPGES-1 and
COX-2, the latter to a higher extent, in 24 h cultures com-
pared to cells treated with TNFα only, as demonstrated
by flow cytometric analysis in Figure 6A. In addition, SP
also decreased mPGES-1 expression in control cells (Fig-
ure 6A). To confirm the effect of SP, JNK phosphorylation
analysis was performed in 1, 3, 6 and 24 h cultures of
fibroblasts stimulated with TNFα in the presence of SP
(10 μM) as shown in Figure 6B. The results, expressed as
phosphorylated JNK (p-JNK) relative to control cells at 1
h, showed a peak in p-JNK at 3 h of incubation, as com-
pared to unstimulated control cells (Figure 6B). The
TNFα-stimulated levels of p-JNK significantly decreased
in the presence of SP (10 μM), compared to cells treated
with TNFα only, at all time points studied (Figure 6B).
Furthermore, the effect of SP on p-JNK was also investi-
gated at an earlier time point, 10 minutes after stimula-
tion (Figure 6C). The results, expressed as
phosphorylated JNK (p-JNK) relative to control cells at
the start of incubation, showed that the TNFα-stimulated
level of p-JNK was decreased to control levels in the pres-
ence of SP (Figure 6C). Concurrent with the protein
expression results of mPGES-1, the inhibitor (5-20 μM)
Figure 4 Gene Ontology analysis of differentially expressed genes. Gingival fibroblasts were cultured with or without TNFα (20 ng/ml), and cDNA 
samples were hybridized to an oligonucleotide microarray. Enrichment analysis was performed to identify biological themes among the genes that 
were differentially expressed in the different comparisons. The plot shows a selection of the gene ontology (GO) categories that were overrepresented 
among the genes having a significant change in expression between 1 h and 3 h due to TNFα treatment. The color of each node illustrates significance 
and can be interpreted in the scale bar, which displays the false discovery rate on a log10 scale. Arrows indicate the parent to child direction. For clarity, 
due to space reasons the figure does not include all significant GO categories. Complete lists of significant GO categories for the different comparisons 
can be found in the additional material (Additional files 2, 5 and 8).
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Table 1: PGE2-synthesizing enzymes and differentially expressed genes in selected significant GO categories (1-3 h).
Symbol Gene Name M-valuea Fold Change p value
PGE2-synthesizing enzymes
PTGES microsomal prostaglandin E synthase-1 (probe 1) 0.65 1.6 2.4 × 10-4
PTGES microsomal prostaglandin E synthase-1 (probe 2) 0.39 1.3 0.09b
PTGES2 microsomal prostaglandin E synthase-2 -0.03 1.0 1.00b
PTGES3 cytosolic prostaglandin E synthase (probe 1) 0.03 1.0 1.00b
PTGES3 cytosolic prostaglandin E synthase (probe 2) 0.16 1.1 0.98b
PTGS2 cyclooxygenase-2 0.50 1.4 0.63b
GO category: Positive regulation of I-kappaB kinase/NF-kappaB cascade
APOL3 apolipoprotein L, 3 1.24 2.4 1.2 × 10-8
IKBKE inhibitor of kappa light polypeptide gene enhancer in B-
cells, kinase epsilon
0.63 1.5 5.1 × 10-4
IKBKE inhibitor of kappa light polypeptide gene enhancer in B-
cells, kinase epsilon
0.50 1.4 3.9 × 10-4
FLNA filamin A, alpha (actin binding protein 280) -0.23 -1.2 0.03
NUP62 nucleoporin 62 kDa 0.35 1.3 1.0 × 10-5
NUP62 nucleoporin 62 kDa 0.37 1.3 9.5 × 10-3
TICAM2 toll-like receptor adaptor molecule 2 0.36 1.3 1.6 × 10-3
CD40 CD40 molecule, TNF receptor superfamily member 5 0.40 1.3 3.6 × 10-3
TLR3 toll-like receptor 3 0.40 1.3 0.01
TFG TRK-fused gene 0.27 1.2 0.04
F2R coagulation factor II (thrombin) receptor -0.22 -1.2 0.05
RIPK2 receptor-interacting serine-threonine kinase 2 1.14 2.2 1.7 × 10-6
TNFRSF10B tumor necrosis factor receptor superfamily, member 
10b
0.35 1.3 1.5 × 10-3
TNF tumor necrosis factor (TNF superfamily, member 2) -0.46 -1.4 2.1 × 10-3
SLC20A1 solute carrier family 20 (phosphate transporter), 
member 1
-1.17 -2.3 1.4 × 10-3
TRIM38 tripartite motif-containing 38 0.33 1.3 0.04
BIRC2 baculoviral IAP repeat-containing 2 0.62 1.5 4.8 × 10-3
GJA1 gap junction protein, alpha 1, 43 kDa -0.64 -1.6 0.02
RELA v-rel reticuloendotheliosis viral oncogene homolog A, 
nuclear factor of kappa light polypeptide gene enhancer 
in B-cells 3, p65 (avian)
0.47 1.4 1.6 × 10-4
GO category: Positive regulation of JNK cascade
EDA2R ectodysplasin A2 receptor -0.34 -1.3 1.3 × 10-3
TLR3 toll-like receptor 3 0.40 1.3 0.01
TAOK3 TAO kinase 3 -0.35 -1.3 0.01
TAOK3 TAO kinase 3 -0.28 -1.2 9.0 × 10-3
HIPK2 homeodomain interacting protein kinase 2 0.40 1.3 3.4 × 10-5
TNF tumor necrosis factor (TNF superfamily, member 2) -0.46 -1.4 2.1 × 10-3
PGE2-synthesizing enzymes and differentially expressed genes in selected significant GO categories when comparing 1 h and 3 h of TNFα 
treatment. aPositive M-values indicate genes up-regulated by TNFα, and negative M-values indicate genes down-regulated by TNFα between 
the 1 h and 3 h time points. bNot differentially expressed in the comparison between time-points 1 h and 3 h. Differential expression is defined 
as p < 0.05.Båge et al. BMC Genomics 2010, 11:241
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also decreased the production of PGE2, both in TNFα-
stimulated cells and in control cells in 24 h cultures, as
shown in Figure 6D.
Involvement of NF-κB in mPGES-1 and COX-2 regulation
In order to evaluate the role of NF-κB in the regulation of
mPGES-1 and COX-2 expression, the NF-κB pathway
inhibitor Bay 11-7082 (Bay) [48] was used in the experi-
ments. Treatment of the cells with Bay (2 μM), decreased
the TNFα-stimulated expression of mPGES-1 and COX-
2, the latter to a higher extent, in 24 h cultures, as demon-
strated by flow cytometric analysis (Figure 7A). In addi-
tion, Bay also slightly decreased mPGES-1 expression in
control cells (Figure 7A). To confirm the inhibition of NF-
κB by Bay, the amount of phosphorylated NF-κB p65 (p-
NFκB) in fibroblasts stimulated with TNFα for 1, 3, 6 and
24 h was analyzed using p-NFκB-specific antibodies (Fig-
ure 7B). The results, expressed as relative to control cells
at the 1 h time point, showed a peak of p-NF-κB at 1 h of
incubation with TNFα (Figure 7B). Treatment of the cells
with Bay (2 μM) in combination with TNFα significantly
decreased p-NF-κB in 1 h cultures, as demonstrated in
Figure 7B. The effect of Bay on p-NF-κB was also studied
at an earlier time point, 10 minutes after stimulation (Fig-
ure 7C). The results, expressed as p-NF-κB relative to
control cells at the start of incubation, showed that at the
10 minute time point, the TNFα-stimulated level of p-
NF-κB was significantly decreased in the presence of Bay
(2.0 μM, Figure 7C). Furthermore, Bay (1-4 μM) reduced
the basal production of PGE2, compared to control cells
in 24 h cultures (Figure 7D). Treatment of TNFα-stimu-
lated cells with Bay (1-4 μM) had no effect on PGE2 pro-
duction in 24 h cultures (Figure 7D), but the inhibitor (2
μM) decreased the TNFα-stimulated PGE2 production in
6 h cultures (Figure 7E). To further confirm the involve-
ment of NF-κB in the regulation of mPGES-1, COX-2 and
PGE2, an additional inhibitor of NF-κB, Ro 106-9920 (Ro)
[49], was used. Treatment of the cells with Ro (4 μM),
decreased the TNFα-stimulated expression of mPGES-1
and COX-2 in 24 h cultures, as demonstrated by flow
cytometric analysis (Figure 8A). Concurrent with the
protein expression results, the inhibitor (4 μM) also
decreased the production of PGE2 in TNFα-stimulated
cells in 24 h cultures, as shown in Figure 8B.
Discussion
PGE2 is involved in numerous inflammatory associated
diseases including the chronic inflammatory disease peri-
odontitis. The aim of this study was to investigate the
global gene expression profile of TNFα-stimulated
human gingival fibroblasts with a focus on signal trans-
duction pathways related to the expression of mPGES-1
and COX-2. We used a time-course factorial design for
the oligonucleotide microarray hybridizations, which
enabled us to statistically discern the interaction effect
between the TNFα treatment and time aspect in the
experiments studied. To our knowledge, this is the first
study investigating the global gene expression profile of
TNFα-stimulated gingival cells as an in vitro model of
gingival inflammation. In the current study, we demon-
strate a TNFα-stimulated up-regulation of mPGES-1 and
COX-2 expression, both at mRNA and protein levels,
accompanied by enhanced PGE2 production. In addition,
our microarray results showed a regulation of immune
response, apoptosis and signal transduction gene catego-
r i e s  i n  r e s p o n s e  t o  T N F α  t r e a t m e n t  o f  g i n g i v a l  f i b r o -
blasts, including positive regulation of the signal
pathways JNK and NF-κB.
The TNFα up-regulated mPGES-1 and COX-2 expres-
sion, accompanied by increased PGE2 production, is in
line with our previously published results on gingival
fibroblasts [30]. In contrast to the mPGES-1 and COX-2
enzymes, the expression of the PGE synthases mPGES-2
and cPGES was not affected by TNFα treatment, high-
lighting the importance of mPGES-1 and COX-2 in the
regulation of inflammatory-induced PGE2  production.
However, when considering the similar kinetics of PGE2
production and COX-2 expression, as well as the magni-
tude of COX-2 induction compared to mPGES-1, COX-2
seems to be the more important enzyme driving the
TNFα induced PGE2 production in gingival fibroblasts.
Increased PGE2 production, via induction of the PGE2-
synthesizing enzymes mPGES-1 or COX-2, has also been
reported in other cell types stimulated with TNFα,
including synovial cells, chondrocytes and colonocytes
[38,50,51].
Various intracellular signaling pathways have been
reported to be involved in inflammatory-induced PGE2
synthesis, mainly through regulation of COX-2, which is
the most widely studied enzyme of the PGE2 synthesis
chain. In contrast, limited reports exist regarding the reg-
ulation of the PGE synthases downstream of COX-2. To
further explore the regulation of mPGES-1 and related
PGE2-synthesizing enzymes in gingival fibroblasts, we
here used a global gene expression profiling approach to
achieve a broader view of the genes and signal pathways
related to the regulation of mPGES-1, in parallel with
COX-2, using microarray analysis of TNFα-treated gingi-
val fibroblasts. The effect of TNFα on global gene expres-
sion profiles has previously been investigated in synovial
fibroblasts, preosteoblasts and HeLa cells, but not in gin-
gival cells [52-56]. With regard to periodontal disease,
microarray analysis of gingival tissue has been used in an
attempt to define subclasses of periodontitis and to evalu-
ate the effect of periodontal therapy [57,58]. In addition,
blood cell gene expression profiling has been performedBåge et al. BMC Genomics 2010, 11:241
http://www.biomedcentral.com/1471-2164/11/241
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in subjects with aggressive periodontitis [59]. Concerning
gingival fibroblasts, microarray studies have been per-
formed on unstimulated cells from healthy and inflamed
gingival tissue, and on IL-1β-stimulated immortalized
cells [60,61]. However, a majority of the abovementioned
microarray studies on cell cultures use only one time
p o i n t  o f  R N A  a n a l y s i s  a f t e r  s t i m u l a t i o n .  I n  t h i s  w o r k ,
using primary gingival fibroblasts, we employed a time-
course factorial design to extract as much relevant infor-
mation as possible from our data set. Commonly, when
using a simpler design for a time series experiment, it
becomes difficult to relate the gene expression differences
at the different time points to each other. This is greatly
facilitated by the use of a time-course factorial design,
which allows for the identification of the genes that are
differentially regulated between the time points due to
TNFα treatment [45].
Our results from the microarray analysis indicated the
JNK and NF-κB pathways as possible targets for inter-
rupting the TNFα-induced signal transduction leading to
increased expression of the PGE2-synthesizing enzymes
mPGES-1 and COX-2. Thus, we next further investigated
the involvement of JNK and NF-κB in the TNFα-stimu-
lated mPGES-1 and COX-2 expression. By using inhibi-
tors specific for these signal pathways, we could
demonstrate that JNK and NF-κB are partly involved in
the complex network of intracellular signal transduction
pathways leading to increased expression of mPGES-1
and COX-2, as well as PGE2 production, in response to
the inflammatory cytokine TNFα. To our knowledge, this
is the first study pointing out the involvement of JNK in
up-regulation of mPGES-1 expression in TNFα-stimu-
lated cells. However, previous studies have shown that
mPGES-1 is stimulated by IL-1β through the JNK path-
way in cardiac myocytes, cardiac fibroblasts and A549
human lung epithelial cells [36,62,63]. In this study we
also show that JNK is involved in TNFα-induced COX-2
e x pr es si on i n gingival  fibr oblas ts,  su gg est ing  t ha t  J NK -
dependent decrease of mPGES-1 may not be the major
event whereby the inhibition of this signal pathway exerts
its effect on PGE2 production. The finding that COX-2
expression was somewhat more influenced by inhibition
of the JNK pathway, suggests that the JNK pathway may
be more significant for COX-2 induction by TNFα in gin-
gival fibroblasts. The involvement of JNK in TNFα-
induced COX-2 expression is in line with results obtained
from human alveolar epithelial cells and murine osteo-
blasts [64,65]. Similarly, IL-1β- and lipopolysaccharide-
induced COX-2 has been shown to be mediated through
JNK in other cell types [66,67]. In contrast, it has also
been reported that COX-2 expression induced by epider-
mal growth factor is unaffected by JNK inhibition in
astrocytes, emphasizing the differences between cell
types as well as the inflammatory stimuli used for investi-
gation of signal transduction pathways [68].
The JNK pathway has been implicated in chronic
inflammatory disorders such as rheumatoid arthritis and
inflammatory bowel disease [69,70]. Moreover, JNK-1
deficiency as well as chemical JNK inhibition has been
demonstrated to prevent joint destruction in rodent
models of rheumatoid arthritis [69,71,72]. Thus, our
novel finding that JNK is partly involved in the regulation
of TNFα-induced mPGES-1 expression, which in concert
with COX-2 regulates PGE2 production in gingival fibro-
blasts, indicates that this signal pathway may also be of
importance in the pathogenesis of periodontitis.
In addition to the JNK pathway, we also found that the
NF-κB pathway was involved in the regulation of
mPGES-1 and COX-2 in gingival fibroblasts stimulated
with TNFα. Our results pointing out the NF-κB pathway
in the regulation of mPGES-1 are in line with our previ-
ous observations [19]. Induction of mPGES-1 expression
using another inflammatory mediator, IL-1β, has been
reported to be mediated by NF-κB in A549 cells [73]. In
regard to COX-2 regulation, the involvement of the NF-
κB pathway in the signal transduction of TNFα-induced
COX-2 expression has been observed in other cell types,
including endothelial cells and astrocytes [74,75]. Con-
Table 2: Differential expression of PGE2-synthesizing enzymes when comparing 1 h and 6 h of TNFα treatment.
Symbol Gene Name M-valuea Fold Change p value
PTGES microsomal prostaglandin E synthase-1 (probe 1) 0.87 1.8 6.2 × 10-7
PTGES microsomal prostaglandin E synthase-1 (probe 2) 0.54 1.5 1.8 × 10-3
PTGES2 microsomal prostaglandin E synthase-2 -0.06 1.0 0.83b
PTGES3 cytosolic prostaglandin E synthase (probe 1) 0.03 1.0 0.78b
PTGES3 cytosolic prostaglandin E synthase (probe 2) 0.03 1.0 0.98b
PTGS2 cyclooxygenase-2 0.85 1.8 0.03
aPositive M-values indicate up-regulated genes, and negative M-values indicate down-regulated genes. bNot differentially expressed in the 
comparison between time-points 1 h and 6 h. Differential expression is defined as p < 0.05.Båge et al. BMC Genomics 2010, 11:241
http://www.biomedcentral.com/1471-2164/11/241
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cerning PGE2 production, no decrease was observed in
TNFα-stimulated PGE2 production in 24 h cultures, in
contrast to the inhibition observed in 6 h cultures. One
reason for the lack of inhibition of PGE2 in 24 h cultures
by the NF-κB inhibitor Bay, in contrast to mPGES-1 and
COX-2 expression, may be a toxic effect of the inhibitor,
affecting the release of PGE2 although no visual signs of
cellular toxicity were observed. However, when using the
NF-κB inhibitor Ro, reported to inhibit NF-κB via selec-
tive inhibition of TNFα-induced IκBα [49], it decreased
the TNFα-stimulated expression of mPGES-1 and COX-2
as well as the production of PGE2 in 24 h cultures. Fur-
thermore, both the NF-κB inhibitors Bay and Ro as well
as the JNK inhibitor SP decreased the basal expression of
mPGES-1 in cells not treated with TNFα, which might be
due to slightly raised basal levels of mPGES-1 expression
resulting from a lingering effect of the serum present in
growth medium before the start of cell culture experi-
ments.
A time-course factorial microarray analysis, like the
one performed in this work, yields massive amounts of
data. In this study we have focused on the signal trans-
duction aspect, especially the JNK and NF-κB pathways,
in order to investigate the regulation of mPGES-1 and
COX-2 expression in relation to PGE2 production. Inhibi-
tion of JNK and NF-κB signal pathwa ys by SP and Ro
abolished the production of PGE2, although the induction
of mPGES-1 and COX-2 by TNFα was not completely
abrogated. One explanation for this might be that other
enzymes may contribute to the production of PGE2 stim-
ulated by TNFα. For instance, it is known that the signal
pathways JNK and NF-κB, in addition to the COX-2 and
mPGES-1 enzymes, are also involved in the regulation of
cPLA2, an upstream key enzyme of the PGE2 synthesis
reported to be induced by TNFα in gingival fibroblasts
[76-78]. Another explanation for the strong inhibition of
PGE2 production, in contrast to the partial reduction of
mPGES-1 and COX-2 expression, may be a synergistic
effect of the concerted inhibition of these two enzymes,
since they are functionally coupled and responsible for
the coordinated PGE2 synthesis [79]. In addition, one has
to be aware that the JNK and NF-κB pathways activated
by TNFα may not be entirely responsible for the
increased expression of mPGES-1 and COX-2. There are
many additional TNFα-regulated genes and pathways
involved in the regulation of inflammatory conditions,
including PGE2 regulatory enzymes, that merit further
study, and investigations are ongoing to continue charting
the genome-wide effect of TNFα on gingival fibroblasts.
Conclusions
We here present for the first time a gene expression pro-
filing approach to explore the signal pathways involved in
the TNFα-stimulated PGE2  production and mPGES-1
and COX-2 expression in gingival fibroblasts. In the
global gene expression profile, the enrichment analysis of
microarray data identified the two signal transduction
pathways JNK and NF-κB as positively regulated by the
inflammatory cytokine TNFα. Inhibitors of the JNK and
NF-κB pathways reduced the TNFα-stimulated expres-
sion of mPGES-1 and to a higher extent COX-2, accom-
panied by abolished PGE2 production. Altogether, the
microarray and phosphorylation data provide insight into
the regulatory network of signal pathways related to PGE
synthase, COX-2 and PGE2 production in gingival fibro-
blasts. The involvement of JNK and NF-κB in the regula-
tion of PGE2 production induced by TNFα in gingival
fibroblasts suggests these two signal pathways as key ele-
ments in the inflammatory-induced PGE2 production in
gingiva, and also as possible attractive targets in the
chronic inflammatory disease periodontitis.
Figure 5 Heat map. A heat map demonstrating the relative level of 
differentially expressed genes between the time points 1 h and 3 h. 
The color of each gene relates to its M-value (log2 ratio of (gene expres-
sion of TNFα treated cells/gene expression of control cells)). A positive 
M-value corresponds to a higher expression in the TNFα treated cells. 
Gene symbols [91] are used for gene identification. The three columns 
represent the three cell lines used in the study. (A) Heat map for the 
GO-term GO:0046330 (positive regulation of JNK cascade). (B) Heat 
map for the GO-term GO:0043123 (positive regulation of I-kappaB ki-
nase/NF-kappaB cascade).
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Figure 6 Involvement of C-Jun N-terminal kinase (JNK) in the regulation of mPGES-1 and COX-2. (A) Gingival fibroblasts were treated with 
TNFα (20 ng/ml) with or without the JNK inhibitor SP600125 (SP, 10 μM) for 24 h. Expression of mPGES-1 and COX-2 was measured by flow cytometry 
using specific antibodies. (B-C) Gingival fibroblasts were treated with TNFα (20 ng/ml) with or without SP (10 μM) for 1, 3, 6 and 24 h (B) or 10 minutes 
(C). Cells were lysed and total protein was analyzed for phosphorylated JNK (p-JNK) and expressed as relative to control cells at 1 h (B) or at start of 
incubation (C). Data is presented as mean ± s.d. Asterisks (*) indicate a significant difference (p < 0.05) between TNFα-stimulated cells and control cells 
at each time point, and hash symbols (#) indicate a significant difference (p < 0.05) between TNFα-stimulated cells and cells treated with TNFα in com-
bination with SP at each time point. (D) Gingival fibroblasts were cultured with the indicated doses of SP in the absence or presence of TNFα (20 ng/
ml) for 24 h. Levels of PGE2 in the culture media were measured by EIA using Luminex technology. Data is presented as mean ± s.d. Asterisks (*) indicate 
a significant difference compared to control cells not treated with TNFα or SP, and hash symbols (#) indicate a significant difference compared to cells 
treated with TNFα only (p < 0.05). The results are representative for all three cell lines and all analyses were performed in triplicates.
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Figure 7 Involvement of Nuclear Factor-kappaB (NF-κB) in mPGES-1 and COX-2 regulation. (A) Gingival fibroblasts were treated with TNFα (20 
ng/ml) with or without the NF-κB pathway inhibitor Bay 11-7082 (Bay, 2.0 μM) for 24 h. Expression of mPGES-1 and COX-2 was measured by flow cy-
tometry using specific antibodies. (B-C) Gingival fibroblasts were treated with TNFα (20 ng/ml) with or without Bay (2.0 μM) for 1, 3, 6 and 24 h (B) or 
10 minutes (C). Cells were lysed and total protein was analyzed for phosphorylated NF-κB p65 (p-NF-κB) and expressed as relative to control cells at 
1 h (B) or at start of incubation (C). Data is presented as mean ± s.d. Asterisks (*) indicate a significant difference (p < 0.05) between TNFα-stimulated 
cells and control cells at each time point, and the hash symbols (#) indicate a significant difference (p < 0.05) between TNFα-stimulated cells and cells 
treated with TNFα together with Bay at each time point. (D) Gingival fibroblast were cultured with the indicated doses of Bay in the absence or pres-
ence of TNFα (20 ng/ml) for 24 h. Levels of PGE2 in the culture media were measured by EIA on a Luminex system, and data is presented as mean ± 
s.d. Asterisks (*) indicate a significant difference from control cells not treated with TNFα or Bay (p < 0.05). (E) Gingival fibroblast were cultured with 
Bay (2 μM) in the absence or presence of TNFα (20 ng/ml) for 6 h. Levels of PGE2 in the culture media were measured by EIA, and data is presented as 
mean ± s.d. Asterisk (*) indicates a significant difference (p < 0.05). The results are representative for all three cell lines and all analyses were performed 
in triplicates.
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Methods
Cell culture of human gingival fibroblasts
Human gingival fibroblasts were established from gingi-
val biopsies obtained from 3 patients, 3 to 12 years of age,
with no clinical signs of periodontal disease. The proto-
col, including the collection of gingival biopsies, was
approved by the Regional Ethics Board in Stockholm
(Dnr 377/98 and 2007/114-31/4). Minced pieces of gingi-
val tissue were explanted to 25 cm2 Falcon tissue culture
flasks containing 5 ml of Dulbecco's Modified Eagle
Medium (DMEM) supplemented with 50 units/ml peni-
cillin, 50 μg/ml streptomycin (50 μg/ml) and 5% fetal calf
serum (FCS, Invitrogen Life Technologies, Scotland, UK).
Gingival fibroblasts were obtained by trypsinization of
the primary outgrowth of cells. The cells were grown at
37°C with 5% CO2 and routinely passaged using 0.025%
trypsin in phosphate-buffered saline (PBS) containing
0.02% EDTA. The fibroblasts used in the experiments
proliferated in the logarithmic phase between the 9th and
14th passage. Gingival fibroblasts were seeded in Petri
dishes in DMEM supplemented with 5% FCS and cul-
tured for 24 h at 37°C. The cell layers were then rinsed
with serum-free DMEM followed by the addition of
DMEM with or without the inflammatory mediator
TNFα (20 ng/ml, according to previous dose-response
studies [19,30]) and in the absence or presence of the
inhibitors SP600125 (SP; Sigma-Aldrich, St. Louis, MO,
USA), Bay 11-7082 (Bay, Sigma-Aldrich) or Ro 106-9920
(Ro, Tocris Bioscience, Bristol, UK). After different incu-
bation periods, as indicated in the figure legends, culture
medium was removed and stored at -20°C for subsequent
PGE2  determination. The cell monolayer was washed
twice with ice-cold PBS and the cells were used for oligo-
nucleotide microarray, flow cytometry or phosphoryla-
tion specific luminex analyses.
RNA extraction
Gingival fibroblasts were seeded and grown as described
above. For each of the three cell lines, two 100-mm Petri
dishes were used for each treatment. After incubation for
1, 3 or 6 h with or without TNFα (20 ng/ml), the cells
were immediately frozen in liquid nitrogen and then
stored at -70°C for subsequent isolation of total RNA.
Total RNA was isolated from fibroblasts using the com-
mercially available RNeasy kit (Qiagen Inc., CA, USA)
and quantified spectrophotometrically at 260/280 nm.
The RNA from each pair of dishes with identical cell line
and treatment were pooled and treated as one sample
throughout further analyses. The RNA quality was
assessed using the RNA 6000 Nano LabChip kit of the
Bioanalyzer system (Agilent Technologies, Palo Alto, CA,
USA).
Labeling and cDNA synthesis for microarray analysis
The synthesis and labeling of cDNA was performed as
previously described by Lindberg et al. 2006[80] Briefly,
cDNA was synthesized using random hexamer primers
(Operon, Alameda CA, USA) and Superscript III (Invit-
rogen, San Diego CA, USA). The reaction was terminated
and the RNA was hydrolyzed with EDTA and HCl. NaOH
w a s  t h e n  u s e d  t o  r e s t o r e  p H  b e f o r e  p r o c e e d i n g  w i t h
cDNA purification using MinElute Reaction Cleanup Kit
(Qiagen, Hilden, Germany). For washing and elution of
the cDNA, 80% EtOH and NaHCO3  pH 9 was used
instead of supplied buffers due to the presence of TRIS,
which would affect the labeling reaction. Labeling was
performed using Cy3 and Cy5 mono-reactive esters from
Amersham-Biosciences (Little Chalfont, Bucks, UK). The
labeling mixture was then purified using MinElute Reac-
tion Cleanup Kit (Qiagen) according to the manufac-
turer's protocol. A Nanodrop instrument (Nanodrop
Technologies, Wilmington, DE USA) was used to confirm
labeling success and to measure fluorophore concentra-
Figure 8 Inhibition of Nuclear Factor-kappaB (NF-κB) by Ro 106-
9920 decreases mPGES-1 and COX-2 expression. (A) Gingival fibro-
blasts were treated with TNFα (20 ng/ml) with or without the NF-κB ac-
tivation inhibitor Ro 106-9920 (Ro, 4.0 μM) for 24 h. Expression of 
mPGES-1 and COX-2 was measured by flow cytometry using specific 
antibodies. (B) Gingival fibroblast were cultured with Ro (4.0 μM) in the 
absence or presence of TNFα (20 ng/ml) for 24 h. Levels of PGE2 in the 
culture media were measured by EIA, and data is presented as mean ± 
s.d. Asterisk (*) indicates a significant difference compared to control 
cells not treated with TNFα or Ro, and the hash symbol (#) indicates a 
significant difference compared to cells treated with TNFα only (p < 
0.05). The results are representative for all three cell lines and all analy-
ses were performed in triplicates.
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tions. The fluorophore concentrations of the labeling
reactions were used to balance the sample volumes. To
obtain equal fluorophore amounts within each hybridiza-
tion, a smaller volume of the sample with a higher fluoro-
phore concentration was hybridized with the entire
volume of the sample with a lower fluorophore concen-
tration.
Oligonucleotide microarray
The oligonucleotide microarrays used in this study were
printed at the KTH microarray core facility [81]. The 70-
mer oligos originate from version 3.03 of Operons
Human Genome Oligo Set, and the microarray contains
35344 features representing 28948 Entrez Gene ID:s [82]
of which 17972 are unique. Additional information
regarding the oligonucleotide microarray can be found in
additional files 10 and 11.
Hybridization
Hybridization was performed as previously described
[80]. Briefly, the microarrays were put in a trough and
prehybridized with a bovine serum albumin based buffer
for 30 minutes in a 42°C water bath. After washing the
microarrays, the corresponding Cy3 and Cy5 labeled
samples were pooled and hybridization buffer was added
to the mixture. Lifter slips (Erie Scientific Company, Shel-
ton, CT, USA) were used to contain the hybridization
mixture on the array during hybridization. The arrays
were then hybridized over night in a 42°C water bath.
After subsequent washing the arrays were immediately
scanned.
Scanning and image processing
Scanning was performed on an Agilent G2565BA scanner
(Agilent Technologies, Palo Alto, CA, USA) using a scan-
ner resolution of 10 μm, as previously described [80]. The
software GenePix 5.1.0.0 (Axon Instruments, Foster City,
CA, USA) was used to extract the raw signals from the
TIFF images and to assign each spot an ID.
Statistical methods and low level analysis of microarray 
data
The data was analyzed using different packages in the
software R [83]. All packages except the KTH package
[81] are available in the Bioconductor open source soft-
ware project for analysis of genomic data [84]. First, the
raw data from GenePix was read into R. Thereafter, four
filters were used to remove spots with abnormal physical
properties, as previously described [80]. On average, 75%
of all spots passed the filters for each slide. After filtering,
the slides were normalized using print tip Lowess nor-
malization [85]. A linear model in the Bioconductor
package LIMMA (Linear models for microarray data) was
set up to estimate the M-value and variance for each
gene. The M-value is the log2 of the fold change (e.g. gene
expression of TNFα treated cells/gene expression of con-
trol cells). Subsequently, differentially expressed (DE)
genes were identified in the different contrasts of interest
by using a moderated t-test where information is bor-
rowed across all features present on the microarray to
obtain a better variance estimate [86]. A false discovery
rate algorithm was then applied to the calculated p values
to correct for multiple testing [87]. Thereafter, differen-
tially expressed genes were defined as genes with a q
value < 0.05 (the false discovery rate analog of a p value),
meaning that the proportion of false positives among the
differentially expressed genes was 0.05. The Gene Ontol-
ogy database was then used to assign functions to genes
[88]. Utilizing the Gene Ontology annotation, enrich-
ment analysis was performed to discover biological
themes among the differentially expressed genes in the
different comparisons [89]. Basically, a conditional hyper-
geometric test is performed for each GO-term where
each gene is counted only in the most specific statistically
significant GO-term to decorrelate and facilitate the
interpretation of the results. False discovery rate was also
used here to correct for multiple testing.
Design of microarray experiments
The experimental design of the microarray study was set
up as a time-course factorial design, to best observe the
TNFα-induced gene expression changes over time [45]. A
C++ program (provided by the authors of reference [45]
on request) was used to determine the exact layout of the
design in order to estimate the interaction effect between
treatment and time, i.e. genes that are differentially
expressed over time, with optimal statistical efficiency
[45]. The experimental design is illustrated in Figure 3A,
where each arrow represents one hybridization. Thus,
each sample was measured four times in this design, and
the design was repeated for each of the three cell lines.
Accession codes
The microarray data set has been deposited at Gene
Expression Omnibus (National Center for Biotechnology
Information), accession number GSE13903 [90].
Flow cytometric analysis
Cells were seeded and grown in 60-mm petri dishes as
described above. After 24 h of treatment, the cells were
collected by trypsinization, and washed three times with
PBS. Thereafter, the cells were fixed in 2% paraformalde-
hyde for 15 min at room temperature (RT) and washed
with PBS prior to permeabilization with SAP buffer con-
taining 0.1% Saponin (Sigma-Aldrich) in PBS (15 min,
RT). The cells were then incubated with primary antibod-
ies for mPGES-1 (monoclonal mouse, Cayman) mPGES-
2 (polyclonal rabbit, Cayman), cPGES (polyclonal rabbit,
Cayman) or COX-2 (monoclonal mouse, Cayman) for 40
min in the dark (RT). Antibodies were titrated in prelimi-Båge et al. BMC Genomics 2010, 11:241
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nary experiments. After washing with SAP-buffer, the
cells were incubated with a secondary goat anti-mouse
Fluorescein Isothiocyanate-labeled antibody (DakoCyto-
mation, Glostrup, Denmark) or sheep anti-rabbit Phyco-
erythrin-labeled antibody (Serotec, Oxford, UK) in the
dark for 40 min at 4°C. Thereafter, the cells were washed
with SAP-buffer, resuspended in PBS and analyzed in a
FACSCalibur™ flow cytometer using CellQuest software
(Becton & Dickinson, San Jose, CA, USA). For each sam-
ple, 10 000 events were acquired and cells were analyzed
regarding the expression of mPGES-1, mPGES-2, cPGES
or COX-2. The results obtained are illustrated as histo-
grams of cell counts, drawn using the program R,
together with the software package rflowcyt [83,84].
Western blot analysis
Cells were seeded and grown in 60-mm petri dishes as
described above. To isolate the total protein, the cells
were washed, resuspended in PBS and centrifuged.
Thereafter, the pellet was resuspended in 100 μl lysis buf-
fer (10 mM HEPES pH 7.9, 10 mM KCl, 0.1 mM EDTA,
0.1 mM EGTA, 1 mM DTT and protease inhibitors: 1
mM PMSF, pepstatin, aprotinin and leupeptin at 1 μg/
ml). The protein concentration of the cell lysates was
determined using the Bradford method (Protein Assay;
Bio-Rad Laboratories, Hercules, CA, USA) using bovine
serum albumin (Sigma-Aldrich) as standard. Equal
amounts of the obtained protein were separated by elec-
trophoresis on a 4-15% linear gradient polyacrylamide
tris-HCl gel (Bio-Rad) and transferred to a nitrocellulose
membrane (Bio-Rad). The membrane was then immersed
in blocking buffer (Tris buffered saline with 0.1% Tween
20, TBST, pH 8.0 with 5% defatted dry milk; Bio-Rad) for
1 h at RT and incubated at 4°C over night in blocking buf-
fer with primary antibody diluted 1:200 for mPGES-1
(monoclonal mouse IgG, Cayman), 1:250 for mPGES-2
(polyclonal rabbit IgG, Cayman), 1:150 for cPGES (poly-
clonal rabbit IgG, Cayman), 1:1000 for COX-2 (monoclo-
nal mouse IgG, Cayman) and 1:20000 for the loading
control actin (polyclonal rabbit IgG, Sigma-Aldrich). Fol-
lowing primary antibody incubation, the membranes
were washed in TBST and incubated for 1 h in RT with
horseradish peroxidase-conjugated secondary antibody,
diluted in blocking buffer (1:1000 goat anti-mouse or
1:2000 swine anti-rabbit; Dako Corporation, A/S, Den-
mark). Finally, the membranes were washed in TBST,
developed using enhanced chemiluminescence (ECL)
(Amersham Biosciences, Bucks, UK) and exposed to
hyperfilm-ECL (Amersham Biosciences).
Analysis of JNK and NF-κB phosphorylation
Cells were seeded and grown in 60-mm petri dishes as
described above. After an incubation period of 1, 3, 6 or
24 h, the cells were scraped in PBS and centrifuged. The
pellet was then resuspended in the lysis solution of the
Bio-Plex Cell Lysis Kit (Bio-Rad) and frozen at -20°C. The
samples were then thawed and centrifuged at 4500 g for
20 min at 4°C, and the supernatant was collected. The
lysate protein concentration was determined using the
Bradford method (Protein Assay; Bio-Rad) with bovine
serum albumin (Sigma-Aldrich) as standard, followed by
addition of an equal volume of assay buffer from the Bio-
Plex phoshpoprotein detection kit (Bio-Rad). The sam-
ples were frozen in -20°C until determination of the
amount of phosphorylated JNK (T183/Y185) or NF-κB
p65 (S536) using Luminex technology on a Bio-Plex Sus-
pension Array System (Bio-Rad) with the Bio-Plex phosh-
poprotein detection kit (Bio-Plex, Bio-Rad) according to
the manufacturer's instructions.
Prostaglandin E2 determination
The amount of PGE2 in the culture media was deter-
mined using Luminex technology on a Bio-Plex Suspen-
sion Array System (Bio-Rad) using a commercially
available enzyme immunoassay (EIA) kit (Cayman), and a
conventional EIA kit (Cayman).
Statistics for non-microarray analyses
All non-microarray experiments were analyzed in tripli-
cates and reproducible data representing one of at least
three independent experiments is demonstrated. Results
are expressed as the mean ± s.d. Student's t test (two-
tailed) was used in the statistical analysis and p values less
than 0.05 were considered statistically significant.
Additional material
Additional file 1 List of differentially expressed genes at 1 h of TNFα 
stimulation. Genes that were differentially expressed in gingival fibroblasts 
due to TNFα treatment at the 1 h time point.
Additional file 2 List of significant Gene Ontology (GO) categories at 
1 h of TNFα stimulation. Significant GO categories due to TNFα stimula-
tion at the 1 h time point, containing the name and number of each GO 
category for reference to the different worksheets of Additional file 3.
Additional file 3 Complete lists of differentially expressed genes in 
the significant GO categories at 1 h of TNFα stimulation. The differen-
tially expressed genes of each significant GO category are listed on a sepa-
rate worksheet, labeled with the GO category number.
Additional file 4 List of differentially expressed genes between 1 and 
3 h of TNFα stimulation. Genes that were differentially expressed in gingi-
val fibroblasts due to TNFα treatment between the 1 h and 3 h time points.
Additional file 5 List of significant Gene Ontology (GO) categories 
between 1 and 3 h of TNFα stimulation. Significant GO categories due to 
TNFα stimulation between the 1 h and 3 h time points, containing the 
name and number of each GO category for reference to the different work-
sheets of Additional file 6.
Additional file 6 Complete lists of differentially expressed genes in 
the significant GO categories between 1 and 3 h of TNFα stimulation. 
The differentially expressed genes of each significant GO category are listed 
on a separate worksheet, labeled with the GO category number.Båge et al. BMC Genomics 2010, 11:241
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